John E. Kraus

1.6k total citations
21 papers, 800 citations indexed

About

John E. Kraus is a scholar working on Psychiatry and Mental health, Molecular Biology and Clinical Psychology. According to data from OpenAlex, John E. Kraus has authored 21 papers receiving a total of 800 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Psychiatry and Mental health, 7 papers in Molecular Biology and 5 papers in Clinical Psychology. Recurrent topics in John E. Kraus's work include Treatment of Major Depression (4 papers), Psychopathy, Forensic Psychiatry, Sexual Offending (3 papers) and Neuroscience and Neuropharmacology Research (3 papers). John E. Kraus is often cited by papers focused on Treatment of Major Depression (4 papers), Psychopathy, Forensic Psychiatry, Sexual Offending (3 papers) and Neuroscience and Neuropharmacology Research (3 papers). John E. Kraus collaborates with scholars based in United States, United Kingdom and France. John E. Kraus's co-authors include Brian Sheitman, Tomoko Maeda‐Chubachi, K. Thomas Robbins, Kelly Gallagher, Miranda Chakos, David E. Nichols, J.A. Lieberman, Gary H. Duncan, Lin Sikich and Richard B. Mailman and has published in prestigious journals such as Journal of the American Chemical Society, Biological Psychiatry and Journal of Medicinal Chemistry.

In The Last Decade

John E. Kraus

20 papers receiving 759 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John E. Kraus United States 14 234 170 162 159 137 21 800
Tiago Mendes Portugal 13 248 1.1× 231 1.4× 113 0.7× 89 0.6× 29 0.2× 32 871
Ihn‐Geun Choi South Korea 14 84 0.4× 120 0.7× 126 0.8× 23 0.1× 67 0.5× 28 674
Margaret Minkwitz United States 17 843 3.6× 59 0.3× 86 0.5× 29 0.2× 76 0.6× 23 1.7k
Julia Boyle United Kingdom 16 43 0.2× 162 1.0× 70 0.4× 13 0.1× 97 0.7× 38 840
Masaaki Tagawa Japan 11 207 0.9× 79 0.5× 32 0.2× 10 0.1× 50 0.4× 20 575
Mehmet Kaya Türkiye 16 266 1.1× 112 0.7× 32 0.2× 68 0.4× 92 0.7× 61 834
Martha A. Bass United States 22 25 0.1× 634 3.7× 370 2.3× 150 0.9× 31 0.2× 61 1.3k
Ken Gordon United States 9 153 0.7× 70 0.4× 23 0.1× 334 2.1× 16 0.1× 24 1.2k
Maryia Zhdanava United States 11 187 0.8× 34 0.2× 49 0.3× 14 0.1× 86 0.6× 70 660
Yukiko Kinoshita Japan 19 178 0.8× 191 1.1× 29 0.2× 7 0.0× 144 1.1× 51 952

Countries citing papers authored by John E. Kraus

Since Specialization
Citations

This map shows the geographic impact of John E. Kraus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Kraus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Kraus more than expected).

Fields of papers citing papers by John E. Kraus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John E. Kraus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Kraus. The network helps show where John E. Kraus may publish in the future.

Co-authorship network of co-authors of John E. Kraus

This figure shows the co-authorship network connecting the top 25 collaborators of John E. Kraus. A scholar is included among the top collaborators of John E. Kraus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John E. Kraus. John E. Kraus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wiśniewski, Kazimierz, John E. Kraus, Karthik Srinivasan, et al.. (2019). Discovery of Potent, Selective, and Short-Acting Peptidic V2 Receptor Agonists. Journal of Medicinal Chemistry. 62(10). 4991–5005. 7 indexed citations
2.
Paller, Amy S., Tomoko Maeda‐Chubachi, Sterling Wu, et al.. (2018). A phase 2, randomized dose-finding study of tapinarof (GSK2894512 cream) for the treatment of atopic dermatitis. Journal of the American Academy of Dermatology. 80(1). 89–98.e3. 129 indexed citations
3.
Robbins, K. Thomas, Robert Bissonnette, Tomoko Maeda‐Chubachi, et al.. (2018). Phase 2, randomized dose-finding study of tapinarof (GSK2894512 cream) for the treatment of plaque psoriasis. Journal of the American Academy of Dermatology. 80(3). 714–721. 73 indexed citations
4.
Findling, Robert L., Kiki Chang, Adelaide S. Robb, et al.. (2015). Adjunctive Maintenance Lamotrigine for Pediatric Bipolar I Disorder: A Placebo-Controlled, Randomized Withdrawal Study. Journal of the American Academy of Child & Adolescent Psychiatry. 54(12). 1020–1031.e3. 31 indexed citations
5.
Flanigan, Kevin M., Thomas Voït, Xiomara Q. Rosales, et al.. (2013). Pharmacokinetics and safety of single doses of drisapersen in non-ambulant subjects with Duchenne muscular dystrophy: Results of a double-blind randomized clinical trial. Neuromuscular Disorders. 24(1). 16–24. 55 indexed citations
6.
Carpenter, David, et al.. (2011). Meta-Analysis of Efficacy and Treatment-Emergent Suicidality in Adults by Psychiatric Indication and Age Subgroup Following Initiation of Paroxetine Therapy. The Journal of Clinical Psychiatry. 72(11). 1503–1514. 34 indexed citations
7.
Grotjahn, Douglas B., John E. Kraus, Hani Amouri, et al.. (2010). Multimodal Study of Secondary Interactions in Cp*Ir Complexes of Imidazolylphosphines Bearing an NH Group. Journal of the American Chemical Society. 132(23). 7919–7934. 25 indexed citations
8.
Kraus, John E., Joseph P. Horrigan, David Carpenter, et al.. (2009). Clinical features of patients with treatment-emergent suicidal behavior following initiation of paroxetine therapy. Journal of Affective Disorders. 120(1-3). 40–47. 13 indexed citations
9.
Sheehan, David V., et al.. (2008). Differences in Medication Adherence and Healthcare Resource Utilization Patterns. CNS Drugs. 22(11). 963–973. 70 indexed citations
10.
Sheitman, Brian, et al.. (2007). Managing Treatment Resistant Violent Adolescents: A Step Forward by Substituting Seclusion for Mechanical Restraint?. Administration and Policy in Mental Health and Mental Health Services Research. 35(3). 198–203. 12 indexed citations
11.
Cook, Alan, et al.. (2005). Implementing a Smoking Ban in an Acute Psychiatric Admissions Unit. Journal of Psychosocial Nursing and Mental Health Services. 43(11). 33–36. 14 indexed citations
12.
Kraus, John E., et al.. (2005). Olanzapine Versus Risperidone in Newly Admitted Acutely Ill Psychotic Patients. The Journal of Clinical Psychiatry. 66(12). 1564–1568. 10 indexed citations
13.
Kraus, John E. & Brian Sheitman. (2005). Clozapine Reduces Violent Behavior in Heterogeneous Diagnostic Groups. Journal of Neuropsychiatry. 17(1). 36–44. 16 indexed citations
14.
Kraus, John E. & Brian Sheitman. (2004). Characteristics of Violent Behavior in a Large State Psychiatric Hospital. Psychiatric Services. 55(2). 183–185. 35 indexed citations
15.
Janowsky, David S., et al.. (2003). Effects of Topiramate on Aggressive, Self-Injurious, and Disruptive/Destructive Behaviors in the Intellectually Disabled: An Open-Label Retrospective Study. Journal of Clinical Psychopharmacology. 23(5). 500–504. 52 indexed citations
16.
Kraus, John E., Diana O. Perkins, & Jeffrey A. Lieberman. (2001). PATHOPHYSIOLOGY OF SCHIZOPHRENIA: Neurodevelopmental and Neurodegenerative Processes.
17.
Lieberman, J.A., Richard B. Mailman, Gary H. Duncan, et al.. (1998). Serotonergic basis of antipsychotic drug effects in schizophrenia. Biological Psychiatry. 44(11). 1099–1117. 159 indexed citations
18.
Kraus, John E. & James O McNamara. (1998). Measurement of NMDA receptor protein subunits in discrete hippocampal regions of kindled animals. Molecular Brain Research. 61(1-2). 114–120. 12 indexed citations
19.
Kraus, John E., J. Victor Nadler, & James O McNamara. (1996). Regulation of alternative splicing of NMDAR1 in the kindling model. Molecular Brain Research. 41(1-2). 97–104. 24 indexed citations
20.
Kraus, John E. & James O McNamara. (1995). Clinical relevance of defects in signalling pathways. Current Opinion in Neurobiology. 5(3). 358–366. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tiago Mendes Breakdown of academic impact, for papers by Ihn‐Geun Choi Breakdown of academic impact, for papers by Margaret Minkwitz Breakdown of academic impact, for papers by Julia Boyle Breakdown of academic impact, for papers by Masaaki Tagawa Breakdown of academic impact, for papers by Mehmet Kaya Breakdown of academic impact, for papers by Martha A. Bass Breakdown of academic impact, for papers by Ken Gordon Breakdown of academic impact, for papers by Maryia Zhdanava Breakdown of academic impact, for papers by Yukiko Kinoshita
Rankless by CCL
2026